Shopping Cart

Your shopping cart is currently empty

LUF 6283

Name: LUF 6283
Brand: TargetMol
SKU: T22938
Price: 32 USD
Availability: InStock
Rating: 5 (10 reviews)

😃Good

Catalog No. T22938Cas No. 92933-48-7

Alias LUF-6283, LUF6283

LUF 6283 is a potent and orally active hydroxycarboxylic acid receptor 2 (HCA2) partial agonist with a Ki value of 0.55 μM, LUF 6283 is capable of producing the beneficial lipid-lowering effects of niacin without inducing the undesirable cutaneous flushing side effect, and is therefore used in dyslipidemia and metabolic research.

LUF 6283

😃Good

Purity: 99.41%

Catalog No. T22938Alias LUF-6283, LUF6283Cas No. 92933-48-7

Pack Size	Price	USA Warehouse	Global Warehouse
1 mg	$32	-	In Stock
5 mg	$73	-	In Stock
10 mg	$98	-	In Stock
25 mg	$169	-	In Stock
50 mg	$253	-	In Stock
100 mg	$376	-	In Stock
1 mL x 10 mM (in DMSO)	$80	-	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:99.41%

Appearance:Solid

Color:White

Resource Download

COA HNMR LCMS

Product Introduction

Bioactivity

Description	LUF 6283 is a potent and orally active hydroxycarboxylic acid receptor 2 (HCA2) partial agonist with a Ki value of 0.55 μM, LUF 6283 is capable of producing the beneficial lipid-lowering effects of niacin without inducing the undesirable cutaneous flushing side effect, and is therefore used in dyslipidemia and metabolic research.
In vitro	LUF 6283 functions as a partial agonist of the HCA2 receptor. In functional biological assays, LUF 6283 induces ERK1/2 phosphorylation with an EC₅₀ value of 0.32 ± 0.06 μM [1].
In vivo	In in vivo studies using C57BL/6 mice, LUF 6283 has been observed to modulate markers of lipid metabolism. Following oral administration via gavage (400 mg/kg, once daily for 4 weeks), the compound results in a reduction in the expression of apolipoprotein B (APOB) [1].
Synonyms	LUF-6283, LUF6283

Chemical Properties

Molecular Weight	168.19
Formula	C₈H₁₂N₂O₂
Cas No.	92933-48-7
Smiles	O=C(O)C1=NNC(=C1)CCCC
Relative Density.	1.31g/cm3

Storage & Solubility Information

Storage

keep away from moisture | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

Ethanol: <16.82 mg/mL, Sonication is recommended.

DMSO: 80 mg/mL (475.65 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1 mg/mL (5.95 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	5.9457 mL	29.7283 mL	59.4566 mL	297.2828 mL
5 mM	1.1891 mL	5.9457 mL	11.8913 mL	59.4566 mL
10 mM	0.5946 mL	2.9728 mL	5.9457 mL	29.7283 mL
20 mM	0.2973 mL	1.4864 mL	2.9728 mL	14.8641 mL
50 mM	0.1189 mL	0.5946 mL	1.1891 mL	5.9457 mL
100 mM	0.0595 mL	0.2973 mL	0.5946 mL	2.9728 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc